Literature DB >> 23440543

Effects of SARA on oxygen-glucose deprivation in PC12 cell line.

Jiao-Qi Wang1, Jin-Ting He, Zhen-Wu Du, Zong-Shu Li, Yong-Feng Liu, Jing Mang, Zhong-Xin Xu.   

Abstract

Ischemic stroke is a major composition of cerebrovascular disease, seriously threatening to human health in the world. Activin A (ActA), belonging to transforming growth factor-beta (TGF-β) super family, plays an important role in the hypoxic-ischemic brain injury through ActA/Smads pathway. While as an essential phosphorylation assistor in TGF-β signaling, the functions and mechanisms of smad anchor for receptor activation (SARA) in ischemic brain injury remain poorly understood. To solve this problem and explore the pathological processes of ischemic stroke, we used an Oxygen-Glucose deprivation (OGD) model in nerve growth factor-induced differentiated rattus PC12 pheochromocytoma cells and down regulated the expressions of SARA by RNA interference technology. Our results showed that the repression of SARA before OGD exposure reduced the expressions of Smad2, 3, 4 mRNA and the phosphorylation rate of Smad2 protein, but it did not affect the mRNA expressions of Smad7. After OGD treatment, ActA/Smads pathway was activated and the expression of SARA in the SARA pre-repression group was significantly up-regulated. The pre-repression of SARA increased the sensitivities of nerve-like cells to OGD damage. Moreover, the mRNA expression of Smad7 which was supposed to participate in the negative feedback of ActA/Smads pathway was also elevated due to OGD injury. Taken together, these results suggest a positive role of SARA in assisting the phosphorylation of Smad2 and maintaining the neuron protective effect of ActA/Smads pathway.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23440543     DOI: 10.1007/s11064-013-1004-5

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  36 in total

Review 1.  Pathobiology of ischaemic stroke: an integrated view.

Authors:  U Dirnagl; C Iadecola; M A Moskowitz
Journal:  Trends Neurosci       Date:  1999-09       Impact factor: 13.837

Review 2.  Rnai as an experimental and therapeutic tool to study and regulate physiological and disease processes.

Authors:  Christopher P Dillon; Peter Sandy; Alessio Nencioni; Stephan Kissler; Douglas A Rubinson; Luk Van Parijs
Journal:  Annu Rev Physiol       Date:  2005       Impact factor: 19.318

Review 3.  Smad transcription factors.

Authors:  Joan Massagué; Joan Seoane; David Wotton
Journal:  Genes Dev       Date:  2005-12-01       Impact factor: 11.361

Review 4.  A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling.

Authors:  Kimberly A Brown; Jennifer A Pietenpol; Harold L Moses
Journal:  J Cell Biochem       Date:  2007-05-01       Impact factor: 4.429

5.  Activin is a neuronal survival factor that is rapidly increased after transient cerebral ischemia and hypoxia in mice.

Authors:  Shibani S Mukerji; Ekaterina A Katsman; Charles Wilber; Noah A Haner; Warren R Selman; Alison K Hall
Journal:  J Cereb Blood Flow Metab       Date:  2006-11-29       Impact factor: 6.200

Review 6.  TGF-beta signalling from cell membrane to nucleus through SMAD proteins.

Authors:  C H Heldin; K Miyazono; P ten Dijke
Journal:  Nature       Date:  1997-12-04       Impact factor: 49.962

7.  PP1 binds Sara and negatively regulates Dpp signaling in Drosophila melanogaster.

Authors:  Daimark Bennett; Luke Alphey
Journal:  Nat Genet       Date:  2002-07-22       Impact factor: 38.330

Review 8.  TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility.

Authors:  Bernhard Schmierer; Caroline S Hill
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

Review 9.  The role of microtubule-associated protein 2 (MAP-2) in neuronal growth, plasticity, and degeneration.

Authors:  G V Johnson; R S Jope
Journal:  J Neurosci Res       Date:  1992-12       Impact factor: 4.164

10.  Neuroprotective effects of exogenous activin A on oxygen-glucose deprivation in PC12 cells.

Authors:  Jin-Ting He; Jing Mang; Chun-Li Mei; Le Yang; Jiao-Qi Wang; Ying Xing; Hong Yang; Zhong-Xin Xu
Journal:  Molecules       Date:  2011-12-30       Impact factor: 4.411

View more
  3 in total

1.  Noncanonical Activin A Signaling in PC12 Cells: A Self-Limiting Feedback Loop.

Authors:  Jiao-Qi Wang; Wen-Zhao Liang; Yang Cui; Jin-Ting He; Hong-Yu Liu; Yue Wang; Long-Xing Xue; Qiu-Ye Ji; Wei Shi; Yan-Kun Shao; Jing Mang; Zhong-Xin Xu
Journal:  Neurochem Res       Date:  2015-12-31       Impact factor: 3.996

2.  Knockdown of microRNA-17-5p Enhances the Neuroprotective Effect of Act A/Smads Signal Loop After Ischemic Injury.

Authors:  Jiao-Qi Wang; Yue Dong; Si-Jia Li; Cheng-Liang Pan; Hong-Yu Liu; Yu-Kai Wang; Lei Xu; Jia-Hui Yang; Yun-Xia Cui; Jin-Ting He; Jing Mang; Zhong-Xin Xu
Journal:  Neurochem Res       Date:  2019-05-15       Impact factor: 3.996

Review 3.  Neuroprotective Effects of Bioactive Compounds and MAPK Pathway Modulation in "Ischemia"-Stressed PC12 Pheochromocytoma Cells.

Authors:  Adi Lahiani; Annette Brand-Yavin; Ephraim Yavin; Philip Lazarovici
Journal:  Brain Sci       Date:  2018-02-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.